Home  >  News
  AstraZeneca receives Chinese marketing approval for Tagrisso to treat EGFR T790M mutation-positive metastatic NSCLC,   March 29, 2017
  Amgen's biosimilar adalimumab receives European marketing approval to treat certain inflammatory diseases,   March 25, 2017
  Ferring Pharma to market CD Investments VSL#3 in Europe and Canada,   March 22, 2017
  Allergan's Juvéderm Vollure XC gets US FDA marketing nod for correction of facial wrinkles, folds in adults over age of 21,   March 21, 2017
  Pfizer gets Chinese FDA approval to market oral JAK inhibitor, Xeljanz to treat adult patients with RA,   March 17, 2017
  Pfizer introduces new antibiotic combo, Zavicefta in UK & Germany to treat complicated infections caused by gram-negative bacteria,   March 16, 2017
  Chugai Pharma to market SBI Pharma's Alaglio Granule 1.5g in Japan,   March 15, 2017
  Mylan introduces exemestane tablets in US market,   March 14, 2017
  VWR to distribute Avantor's beaker-to-bulk portfolio of J.T.Baker & Macron Fine Chemicals laboratory, pharma products in EU,   March 11, 2017
  Daiichi Sankyo introduces generic oxycodone ER tablets to treat sustained cancer pain,   March 09, 2017
  Cadila gets US FDA nod to market Tizanidine HCl capsules,   March 08, 2017
  US FDA, EMA accept 3 marketing applications filing for ertugliflozin-containing medicines for adults with type 2 diabetes,   March 08, 2017
  Melinta, Menarini sign development & commercialization pact for Delafloxacin in 68 countries,   March 04, 2017
  Lupin receives US FDA approval to market generic Percocet tablets and Suprep Bowel Prep Kit,   February 28, 2017
  Astellas to market Kyowa Pharma’s quetiapine fumarate ER tablets in Japan,   February 28, 2017
  Endo Pharma recalls one lot of Edex 10 mcg 2 pack carton due to potential lack of sterility assurance,   February 27, 2017
  Zydus’ subsidiary Nesher Pharma gets US FDA nod to market oseltamivir phosphate capsules,   February 27, 2017
  Ortho seeks US FDA marketing approval for VITROS HIV combo assay for use on Vitros 3600 immunodiagnostic system,   February 27, 2017
  Zydus Cadila receives approvals from DCGI, CDSCO and CDL to market tetravalent inactivated influenza vaccine VaxiFlu-4,   February 24, 2017
  Adapt Pharma seeks European marketing approval for naloxone HCl nasal spray to treat opioid overdose,   February 23, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |